10 Things Worth Pay...
Health Care: Drugs
ACADIA Pharmaceuticals Inc. (ACAD: NASDAQ)
$1.33 0.02 | 1.53%
06/04/12 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 1.31 |
| 52 Week High | 2.30 |
| 52 Week Low | 0.90 |
| Avg. Daily Vol. (Mil) | 0.51 |
| Beta (3 year) | 3.25 |
| Share Related Items | |
| Mkt Cap (Mil) | 69.33 |
| Shares Out (Mil) | 52.93 |
| Float (Mil) | 52.65 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 4.00 |
| Current Ratio | 4.10 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 33.30 |
| Price/Book | 3.94 |
| Price/Cash Flow | -3.00 |
| Per Share Data | |
| Earnings | -0.44 |
| Sales | 0.04 |
| Book Value | 0.33 |
| Cash Flow | -0.43 |
| Business Summary | |
|---|---|
| ACADIA Pharmaceuticals Inc. is focused on the development and commercialization of small molecule drugs for the treatment of central nervous system disorders. | |
| General Information | |
| 3911 Sorrento Valley Bouleva
San Diego, CA 92121 |
|
| www.acadia-pharm.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 24 | |
| CEO: Dr. Uli Hacksell,PhD | |
| Short Interest | |
| Current Month (Mil) | 2.47 |
| Previous Month (Mil) | 2.60 |
| Short Interest Ratio (Days) | 8.70 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -87.30 |
| Return on Investments | -131.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with ACAD
- Portfolio NameUser Type
- Contributor22 Biopharma Stocks With Br...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserBerliner
- Contributor5 Stocks Under-$10 Setting ...
- Contributor10 Pharma Stocks Under $3
- Userazfar
- UserMy Portfolio
- UserNUKE PORTFOLIO
Latest ACAD Headlines from TheStreet
- 22 Biopharma Stocks With Breakout Potential in 2012 05.22.12 | 08:05 am
- ACADIA Stock Gaps Down On Today's Open (ACAD) 04.26.12 | 09:04 am
- ACADIA Pharmaceuticals Inc. Stock Downgraded (ACAD) 04.11.12 | 05:04 am
- 8 Stocks Under $10 Moving Higher 03.20.12 | 12:03 pm
- ACADIA Stock Soars (ACAD) 03.13.12 | 03:03 pm
- 5 Stocks Under $5 Making Big Moves 03.13.12 | 02:03 pm
- ACADIA Stock Soars (ACAD) 01.18.12 | 04:01 pm
- 7 Stocks Under $10 Ripping Higher 12.20.11 | 02:12 pm
- Acadia Pharmaceuticals: Investing With No Safety Net 06.24.11 | 10:06 am
- 10 Pharma Stocks Under $3 06.16.11 | 01:06 pm
Press Releases for ACAD
- ACADIA Pharmaceuticals To Webcast Educational Program On Parkinson’s Disease Psychosis On May 22, 2012 - Business Wire 05.15.12 | 09:05 am
- ACADIA Pharmaceuticals Reports First Quarter 2012 Financial Results - Business Wire 05.08.12 | 04:05 pm
- ACADIA Pharmaceuticals To Present At The 19th Annual Future Leaders In The Biotech Industry Conference On April 20, 2012 - Business Wire 04.13.12 | 09:04 am
- ACADIA Pharmaceuticals To Present At The 11th Annual Needham Healthcare Conference On April 3, 2012 - Business Wire 03.28.12 | 09:03 am
- ACADIA Pharmaceuticals Awarded New Grant From The Michael J. Fox Foundation For Development Of Nurr1-RXR Selective Agonists To Treat Parkinson’s Disease - Business Wire 03.27.12 | 09:03 am
- ACADIA Pharmaceuticals Reports Financial Results For The Fourth Quarter And Year Ended December 31, 2011 - Business Wire 03.06.12 | 04:03 pm
- ACADIA Pharmaceuticals Announces Extension Of Drug Discovery Collaboration With Allergan, Inc. - Business Wire 03.05.12 | 09:03 am
- ACADIA Pharmaceuticals To Present At Upcoming Investor Conferences - Business Wire 02.29.12 | 09:02 am
- ACADIA Pharmaceuticals To Announce Fourth Quarter And Full Year 2011 Financial Results On March 6, 2012 - Business Wire 02.28.12 | 09:02 am
- ACADIA Pharmaceuticals To Present At The 14th Annual BIO CEO & Investor Conference On February 13, 2012 - Business Wire 02.06.12 | 09:02 am
Partner Headlines for ACAD
- Time To Take Another Look At The Biotechnology Sector - Seeking Alpha 04.09.12 | 09:04 am
- Why Antares Pharma Should Be On Your List For Long-Term Investment - Seeking Alpha 03.16.12 | 08:03 am
- Bio-Pharma Watch List: 2 Week Report Card - Seeking Alpha 03.12.12 | 09:03 am
- 7 Healthcare Stocks Undervalued By Earnings Growth And Cash Flows - Seeking Alpha 02.03.12 | 07:02 pm
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 01.25.12 | 09:01 am
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 01.23.12 | 09:01 am
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 01.19.12 | 09:01 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 01.17.12 | 09:01 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 01.13.12 | 09:01 am
- 10 Biotech Stocks Undervalued By Levered Free Cash Flows - Seeking Alpha 12.07.11 | 08:12 am
